Credits: Canva
Japan could become one of the first countries in the world to end the HIV epidemic, says the president of Gilead Sciences Japan, Kennet Brysting. The idea for now could seem a little too ambitious, but it is not entirely unrealistic, given that the availability of medicines that can prevent transmission of HIV. Drugs are not the cure, but control over the spread of virus to the point where the disease is no longer a major public health threat.
Gilead's have two key drugs, Truvada and lenacapavir. These two are playing a crucial role in prevention. Truvada is taken as a daily pill, while lenacapavir requires two injections per year. It can make the virus undetectable in infected individuals and prevent transmission to those who are not infected yet. In trials, lenacapavir showed 100% efficacy in preventing HIV infections. This is why it is describe as "almost a vaccine".
In 2024, Japan also approved Truvada for HIV prevention, but the country has yet to approve lenacapavir for the same. Until now, people in Japan had been importing generic versions of Truvada or purchasing it from clinics that source it from overseas.
Up until now, Japan reported around 25,000 HIV infections, whereas 669 new cases were reported in 2023. For seven consecutive years, the number of new infections remained under 1,000. The downward trend thus shows that the virus has been controlled, however, getting to zero new infections remains the ultimate goal.
Brysting too acknowledged that simply having effective drug is not enough. What is important is to have a proper implementation, access and healthcare support to make sure that these treatments are widely available and effective.
The biggest challenges is testing rates. There is a need to increase testing rates. At this very moment, around 86% people infective with Japan have been tested, but the goal is to increase it up to 95%, with an ideal goal of 100%. Without widespread testing, many infected people may not even know that they are infected and it could transmit the virus.
Another measure issue is the cost of preventative medication. While Japan's health insurance covers treatments for diseases, it does not cover preventative drugs. Those who purchase Truvada for prevention, pay around $470 per month. Some clinics in Tokyo offer generic alternatives too, which is cheaper, but they are not ideal.
Brysting expressed concern that individuals importing medications might not be consulting doctors regularly, which is essential for monitoring HIV status and overall health. Truvada users need to be tested for HIV initially and every three months, along with screenings for other infections and kidney function checks. Without proper medical supervision, there is a risk of misuse and inadequate protection.
Gilead is in discussions with Japanese authorities to improve access and insurance coverage for Truvada, and progress is being made. Japan has shown efficiency in approving critical medicines, as seen during the COVID-19 pandemic when Gilead’s remdesivir was approved in just three days.
Gilead at this moment is not only focused on HIV and hepatitis C, but also expanding into oncology with innovative treatments like CAR-T cell therapy, which strengthens a patient's immune system to fight cancer.
However, Japan’s strict approval processes can slow down drug availability. Phase 3 clinical trials often need to be conducted within the country, and Japan tends to approve medicines much later than other regions. For instance, Truvada was approved for prevention in Japan 12 years after the U.S. and nearly 20 years after its approval for treatment. inancial factors also play a role. The Japanese government adjusts drug prices annually, often reducing them, which can make long-term investment challenging for pharmaceutical companies.
Credits: Canva
From time and again experts have highlighted that flu has come early this year. In fact, they have predicted that this could be a 'nasty season', all thanks to the mutated version of H3N2 virus.
Known as the superfly, this is H3N2 'subclade K'. It is a type of seasonal influenza A virus and people have not encountered much of it in the recent years. This is why there is less immunity against it. However, the National Health Service (NHS), UK, has already sent out a 'flu jab SOS' to vulnerable people.
NHS has confirmed that the super flu is circulating in England this year, and due to less immunity, it is making it easier to spread across people. The UK Health Security Agency (UKHSA) has urged people to get a flu jab. As per the early data, this year's vaccine has offered good protection despite the new strain.
Daniel Elkeles, chief executive of NHS Providers, said that the major concern is that H3N2 is associated with a more severe illness and superflu could be "a very nasty strain of flu". He said that UK could be experiencing a "tidal wave" of illness.
Read More: Unique Symptoms Of H3N2 Flu Strain In UK And How Long Infection Now Last
NHS offers free flu jabs to people who need it the most, which includes:
NHS also includes frontline health and social care workers to get the jab.
The flu jab is also available in a nasal spray version, which could be administered to children aged 2 to 3 years as well as school-aged children, up to year 11.
Everyone else who is not in this list have to buy the jab.
Even if you are healthy, you should get the shot, say doctors. Vaccines are still working against the drifted influenza A (H3N2) subclade, also known as the super flu. The vaccines in high street chemists are sold for £20.
Anyone can be vaccinated, except for those who have a serious allergy to any of its ingredients or to the vaccine it self. The best way to know is to speak to the pharmacist and your GP.
For the vaccine to work, it usually takes up to 14 days. However, what is more important to not is that during the 14-day-long period, you are still vulnerable to catching the virus.
Some people think that it is the flu vaccine itself that has given them the flu, however, the truth is that while vaccine does not give you a flu, it gives your body the instruction it needs to fight off an infection, in case you catch it. While you may still catch the flu after being vaccinated, the affects will be milder and would not last as long.
The best part, the vaccine is frequently updated to match the strain or the version of flu that experts expect will be circulating.
Also Read: This ONE Key Symptom Will Help You Differentiate Flu From COVID, According To Doctor
Elkeles says that anyone experiencing flu or cold symptoms should wear a mask in public places. This is important for the "tidal wave" of illness in the UK. Speaking to Times Radio, he said, "When you were talking about anything like Covid, I think we need to get back into the habit that if you are coughing and sneezing, but you’re not unwell enough to not go to work, then you must wear a mask when you’re in public spaces, including on public transport, to stop the chances of you giving your virus to somebody else. And we were all very good about infection control during Covid. And we really, really need to get back to that now.”
Credits: Canva and Instagram
Justin Timberlake had publicly revealed in his Instagram post about his diagnoses of Lyme disease, a tick borne illness that can cause lingering and unpredictable symptoms. The 44-year-old pop icon shared how this condition caused him "massive nerve pain", fatigue, and other symptoms as he went on his World Tour.
However, he did note that if diagnosed at an early stage, the condition is also treatable. It is spread by infected blacklegged ticks.
In an Instagram post, he revealed that he had been battling with some health issues. In a report by PEOPLE, a source close to Jessica Biel said that the singer is prioritizing his health after the "grueling tour and Lyme disease diagnosis".
Timberlake disclosed that during his Forget Tomorrow World Tour, which promoted his sixth solo album Everything I Thought It Was, he had been quietly “battling some health issues.”
“When I first got the diagnosis, I was shocked for sure,” Timberlake wrote. “But at least I could understand why I would be onstage and in a massive amount of nerve pain, or just feeling crazy fatigue or sickness.”
He admitted that the symptoms forced him to reconsider continuing the tour, saying, “I was faced with a personal decision. Stop touring? I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling.”
Despite the physical toll, Timberlake pushed through his JT LIVE 25 tour leg, which included festival performances like Lollapalooza Brazil, before finally wrapping things up on July 31.
Lyme disease is caused by bacteria transmitted to humans through the bite of an infected black-legged tick. It's most common in certain parts of North America and Europe, especially during the warmer months.
The most common early sign of Lyme is a red rash that often resembles a bull’s-eye, typically appearing within 3 to 30 days after the bite.
The Center for Disease Control and Prevention (CDC), US, notes that the early symptoms can also mimic the flu, fever, chills, headache, fatigue, and muscle aches. If caught early and treated with antibiotics, most people recover completely within a few weeks.
However, for some, like Timberlake, symptoms can persist or worsen even after treatment. This condition, sometimes called Post-Treatment Lyme Disease Syndrome (PTLDS), includes ongoing fatigue, nerve pain, cognitive issues, and more.
“Lyme can be incredibly tricky because its symptoms overlap with many other conditions,” explained Dr. Christopher Bazzoli, an emergency medicine expert at the Cleveland Clinic, as reported by the New York Times. “When it’s not caught early, it can lead to a wide range of complications, from joint pain to neurological issues.”
In some untreated or severe cases, complications can include:
Doctors are still researching why some people recover quickly while others experience long-term effects. For now, treatment usually includes rest, medications for symptom relief, and in some cases, extended antibiotic therapy.
Timberlake has now joined a growing list of celebrities, including Avril Lavigne and Shania Twain, who’ve opened up about their experiences with Lyme disease in hopes of raising awareness.
Takeaway For You: If you’ve spent time in wooded or grassy areas and experience unusual fatigue, joint pain, or rashes, it’s worth getting checked for Lyme. Early diagnosis can make all the difference.
Credits: Canva
Scromting: the blend of two nightmares - screaming and vomiting. It sounds surreal, but it is as real as it could get. In an interview with the New York Post, Sydni Collins, 23, shared that she was "puking all morning." "I would let out yells or cries because nothing would come out. I was just dry heaving," she shares. This is how she ended up in the hospital with a feeding tube. What she was experiencing is called cannabis hyperemesis syndrome (CHS), a debilitating condition that triggers episodes of relentless nausea, abdominal pain, and severe vomiting in chronic weed users. She has been smoking weed daily as a teenager, since she was 16.
In the US, there are more than 2.5 million teens and 1 in 10 of them are casual cannabis users, with an additional of 600,000 teens considered to be addicted to it. Emergency rooms in the country have seen a steady rise in CHS cases over the last decade. In fact, the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have also added CHS in its official diagnostic codes.
In Collins story, she became the trendsetter, because during her first hospital visit, she did not receive the diagnosis. However, her inability to eat a full meal afterward is what led to 7 ER visits in just one month. When she was finally admitted, she was only 87 pounds. She shared she would be in fetal position on the beds for hours, because that was the only way her stomach did not hurt. This is when she was finally diagnosed with 'superior mesenteric artery syndrome', which is a rare digestive disorder.
Misdiagnosis is common because there had been an absence of a diagnostic code for CHS.
Dr David Streem, medical director of the Cleveland Clinic's Alcohol and Drug Recovery Center told USA TODAY that he has treated a range of patients with CHS over the years. He said that the condition is so severe that even the strongest anti-nausea medication that are given to chemotherapy patients, like Ondansetron, did not stop it.
However, there is a debate on CHS patients, and marijuana advocates like Paul Armentano, who is the deputy director of cannabis reform organization NORML, tells USA TODAY that CHS is actually "very rare" and that a lack of research on the syndrome has led to its misunderstanding. Armentano says, "The very fact that we're rebranding what was known for two decades as cannabinoid hyperemesis syndrome as scromiting. Scromiting is clearly sensational." It is made up, non-scientific, and sensational, says the cannabis advocate.
It is a side effect of prolonged use of marijuana. This results in nausea, vomiting, and abdominal pain.
As per Rome Foundation, a patients must meet the following criteria:
CHS was first reported in Australian medical literature in 2004. This is when a small study, published in BMJ analyzed 19 patients with cyclical vomiting after prolonged marijuana use.
While the research on what actually suddenly causes this syndrome is very limited, Armentano asks questions on if synthetic cannabis products, or a specific type of it leads to such a medical condition.
Stream said for treatment, IV drip of substance such as droperidol and haloperidol are often used in emergency rooms for CHS. Stream also said that Capsaicin, commonly referred to as hot pepper cream could also be rubbed on the abdomen for some temporary relief, along with hot showers or baths.
© 2024 Bennett, Coleman & Company Limited